Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery.

Saxton, Judith, McGonigle-Gibson, Karen L., Swihart, Andrew A., Miller, Vicki J.·1990·Psychological Assessment

Cited by (15)

  1. Rivastigmine for Alzheimer’s disease.
    Birks, Jacqueline S, Chong, Lee-Yee, Grimley Evans, John · 2015 · Cochrane Database of Systematic Reviews
  2. Donepezil for the Treatment of Agitation in Alzheimer's Disease
    Howard, Robert J., Juszczak, Edmund, Ballard, Clive G., Bentham, Peter, Brown, Richard G., Bullock, Roger, Burns, Alistair S., Holmes, Clive, Jacoby, Robin, Johnson, Tony et al. · 2007 · New England Journal of Medicine
  3. Severe Impairment Battery: A Neuropsychological Test for Severely Demented Patients
    Panisset, Michel · 1994 · Archives of Neurology
  4. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
    Ballard, Clive, Margallo-Lana, Marisa, Juszczak, Edmund, Douglas, Simon, Swann, Alan, Thomas, Alan, O'Brien, John, Everratt, Anna, Sadler, Stuart, Maddison, Clare et al. · 2005 · BMJ
  5. Rivastigmine for Alzheimer's disease
    Birks, Jacqueline, Grimley Evans, John, Iakovidou, Vasso, Tsolaki, Magda · 2009 · Cochrane Database of Systematic Reviews
  6. Relationship between Serum and Brain Carotenoids,α-Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study
    Johnson, Elizabeth J., Vishwanathan, Rohini, Johnson, Mary Ann, Hausman, Dorothy B., Davey, Adam, Scott, Tammy M., Green, Robert C., Miller, L. Stephen, Gearing, Marla, Woodard, John et al. · 2013 · Journal of Aging Research
  7. The Test for Severe Impairment: An Instrument for the Assessment of Patients with Severe Cognitive Dysfunction
    Albert, Marilyn, Cohen, Carolyn · 1992 · Journal of the American Geriatrics Society
  8. A Double-Blind Comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia
    Pollock, Bruce G., Mulsant, Benoit H., Rosen, Jules, Mazumdar, Sati, Blakesley, Richard E., Houck, Patricia R., Huber, Kimberly A. · 2007 · The American Journal of Geriatric Psychiatry
  9. Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
    Fox, Chris, Crugel, Monica, Maidment, Ian, Auestad, Bjorn Henrik, Coulton, Simon, Treloar, Adrian, Ballard, Clive, Boustani, Malaz, Katona, Cornelius, Livingston, Gill · 2012 · PLoS ONE
  10. The staging and assessment of moderate to severe Alzheimer disease
    Feldman, H. H., Woodward, M. · 2005 · Neurology
  11. Diagnosis and Treatment of Patients with Severe Alzheimer’s Disease
    Voisin, Thierry, Vellas, Bruno · 2009 · Drugs & Aging
  12. Cognitive Response to Memantine in Moderate to Severe Alzheimer Disease Patients Already Receiving Donepezil: An Exploratory Reanalysis
    Schmitt, Frederick A., van Dyck, Christopher H., Wichems, Christine H., Olin, Jason T. · 2006 · Alzheimer Disease & Associated Disorders
  13. The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia
    Sun, Meng, Mainland, Brian J., Ornstein, Tisha J., Mallya, Sasha, Fiocco, Alexandra J., Sin, Gwen Li, Shulman, Kenneth I., Herrmann, Nathan · 2018 · International Journal of Geriatric Psychiatry
  14. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes
    Wicklund, Alissa H., Rademaker, Alfred, Johnson, Nancy, Weitner, Bing Bing, Weintraub, Sandra · 2007 · Alzheimer Disease & Associated Disorders
  15. Cognitive Changes 5 Years After Coronary Artery Bypass Grafting: Is There Evidence of Late Decline?
    Selnes, Ola A., Royall, Richard M., Grega, Maura A., Borowicz, Jr, Louis M., Quaskey, Shirley, McKhann, Guy M. · 2001 · Archives of Neurology

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.